Literature DB >> 15367446

Use of Eprex in Canada.

Carole Légaré, Christopher Turner, Anges V Klein.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15367446      PMCID： PMC516175          DOI： 10.1503/cmaj.1041010

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  2 in total

1.  Eprex warning issued, but no ban.

Authors:  Barbara Sibbald
Journal:  CMAJ       Date:  2004-03-02       Impact factor: 8.262

2.  Pure red-cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin.

Authors:  Nicole Casadevall; Joelle Nataf; Beatrice Viron; Amir Kolta; Jean-Jacques Kiladjian; Philippe Martin-Dupont; Patrick Michaud; Thomas Papo; Valerie Ugo; Irene Teyssandier; Bruno Varet; Patrick Mayeux
Journal:  N Engl J Med       Date:  2002-02-14       Impact factor: 91.245
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.